Form 4: CollPlant Biotechnologies CEO Receives Stock Grant
Insider Transaction (Form 4)
Eran Rotem, Deputy CEO and CFO of CollPlant Biotechnologies Ltd, received 510,372 shares of common stock on September 3, 2026.
Summary
- Grant/award: acquired 510,372 Ordinary Shares on September 3, 2026; holds 516,372 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Eran Rotem — Officer (Deputy CEO and CFO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-03 | Grant/award | Ordinary Shares | 510,372 | — | — | 516,372 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-03 | Grant/award (510,372 shares) |
Keywords
insider transaction, Form 4, CLGN, CollPlant Biotechnologies Ltd, neutral, Eran Rotem
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.